ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meeting Abstracts
    • All Meetings
    • PRSYM 2026
    • ACR Convergence 2025
    • Download Abstract Supplements
  • Keyword Index
  • Search
  • My Favorites
    • View and print all favorites
    • Clear all favorites

Abstract Number: 0395

Assessment of Enthesitis by Pediatric Rheumatology Providers

Erin Treemarcki1, Shirley Tse2, Marisa Klein-Gitelman3, Adam Mayer4, Hemalatha Srinivasalu5, Heather Walters6 and Melissa Oliver7, and the CARRA Juvenile Spondyloarthritis Workgroup and the CARRA investigators, 1University of Utah, Salt Lake City, UT, 2SickKids, Toronto, ON, Canada, 3Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago, IL, 4University of Pennsylvania/Children's Hospital of Philadelphia, Philadelphia, PA, 5Children's National Hospital, Washington, DC, 6Northwell Health, New Hyde Park, NY, 7Indiana University, Indianapolis, IN

Meeting: ACR Convergence 2024

Keywords: Juvenile idiopathic arthritis, Pediatric rheumatology, spondyloarthritis, Surveys

  • Tweet
  • Email a link to a friend (Opens in new window) Email
  • Print (Opens in new window) Print
Session Information

Date: Saturday, November 16, 2024

Title: Pediatric Rheumatology – Clinical Poster I

Session Type: Poster Session A

Session Time: 10:30AM-12:30PM

Background/Purpose: Enthesitis is a characteristic feature of enthesitis related arthritis (ERA) but can be found in other juvenile idiopathic arthritis (JIA) subtypes. It occurs with greater frequency in juvenile ERA than in adult-onset ankylosing spondylitis.  Enthesitis indices exist for adults with spondyloarthritis, but there is no such measure for pediatric patients. This introduces the potential for variability in assessing for enthesitis and diagnosing enthesitis. We aimed to determine the frequency of and indications for assessing enthesitis in clinical practice in addition to the sites most assessed and what factors contribute to the diagnosis of enthesitis.

Methods: A survey was developed and refined by members of the CARRA Juvenile Spondyloarthritis (JSpA) Workgroup. The survey was then further refined using input from experts at the CARRA JIA Forum and through pilot testing. Survey questions included demographics, practice patterns around assessment of enthesitis, and knowledge of enthesitis. The survey was distributed electronically to CARRA members with reminders sent every 2 weeks over a 2-month period. Responses were analyzed using descriptive statistics.

Results: Of the 343 who opened the survey, 139 responded (40.5% response rate).  Respondents were predominantly pediatric rheumatologists (76.3%) at academic medical centers (91.1%) in the US (86.0%) (Table 1). Providers were asked in which scenarios they routinely assess enthesitis, and the top answers were patients with ERA (92.6%); patients with HLA B27 associated conditions such as uveitis, psoriasis and inflammatory bowel disease (86.8%); JPsA (85.1%); new patients with concern for JIA (80.1%); and undifferentiated JIA (76.0%). Only 4% of respondents use an established enthesitis scoring measure, but most are interested in a scoring tool being created for pediatric patients (83.3%). The most assessed sites for enthesitis were in the lower extremities with the Achilles tendon being assessed by all respondents (Figure 1). Reported features most concerning for enthesitis were tenderness (100%), swelling (81.7%), and pain with motion/heel walk/squatting (73.9%).

Conclusion: Most providers are interested in a pediatric-specific enthesitis scoring system. There are similarities in current practice patterns in clinical enthesitis evaluation with a higher likelihood of checking for enthesitis in certain JIA subtypes with entheseal sites in the lower extremities most commonly evaluated. Future steps include development of a pediatric enthesitis scoring tool that would standardize enthesitis evaluation and could be used as both a clinical and research tool.

Supporting image 1

Table 1. Respondent demographics.

Supporting image 2

Table 2. Assessment of enthesitis in clinical practice.

Supporting image 3

Figure 1: Entheses routinely assessed on exam by respondents.


Disclosures: E. Treemarcki: None; S. Tse: None; M. Klein-Gitelman: AbbVie/Abbott, 2, AstraZeneca, 2, Eli Lilly, 1; A. Mayer: None; H. Srinivasalu: None; H. Walters: None; M. Oliver: None.

To cite this abstract in AMA style:

Treemarcki E, Tse S, Klein-Gitelman M, Mayer A, Srinivasalu H, Walters H, Oliver M. Assessment of Enthesitis by Pediatric Rheumatology Providers [abstract]. Arthritis Rheumatol. 2024; 76 (suppl 9). https://acrabstracts.org/abstract/assessment-of-enthesitis-by-pediatric-rheumatology-providers/. Accessed .
  • Tweet
  • Email a link to a friend (Opens in new window) Email
  • Print (Opens in new window) Print

« Back to ACR Convergence 2024

ACR Meeting Abstracts - https://acrabstracts.org/abstract/assessment-of-enthesitis-by-pediatric-rheumatology-providers/

Advanced Search

My Favorites

Save and print abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract (must have cookies enabled in browser). See saved favorites.

Abstract Policies

  • ACR Convergence Abstract Embargo Policies
  • ACR Convergence Abstract Permissions & Reprints
  • PRSYM Abstract Policies

ACR Convergence. Where Rheumatology Meets

ACR Convergence 2026

Join us November 6-11 in Orlando, Florida.
See Registration Information

  • Contact ACR
  • Privacy Policy
  • ACR Policies
  • Cookie Preferences

© Copyright 2026 American College of Rheumatology